. (2019). Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK. J Cancer Surviv. http://doi.org/10.1007/s11764-019-00782-w
UK data driving real-world evidence